6 – 10 of 35
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Master protocols in clinical trials : a universal Swiss Army knife?
(
- Contribution to journal › Scientific review
-
Mark
Tomosynthesis in breast screening : great expectations?
(
- Contribution to journal › Article
- 2018
-
Mark
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer : meta-analysis of individual patient data from ten randomised trials
- Contribution to journal › Scientific review
- 2016
-
Mark
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.
(
- Contribution to journal › Article
-
Mark
Morcellation and risk of malignancy in presumed ovarian fibromas/fibrothecomas
(
- Contribution to journal › Debate/Note/Editorial